top of page
Evicure_logo_logo_color (002).png
Screenshot 2024-08-04 at 11_edited.jpg

About us

EviCure is a pre-clinical stage biopharmaceutical company, leveraging AI and sophisticated experimental disease models for developing extracellular vesicle (EV) -based therapies for cancer. ​

The company platform consists of extracellular vesicles with inherent anti-tumor abilities combined with targeted delivery capabilities of different types of therapeutics.

Identification of extracellular vesicle subpopulations with specific activities

Using EVs for targeted delivery of different types of drugs and treatments

Novel scale-up technologies

EviCure's Technologies

Identification of EV subpopulations with specific activities

Novel scale-up technologies for generation of consistent and defined therapeutic EVs

EVs for targeted delivery of different types of drugs and treatments

AI-based scale up platform

AI slide _edited.png
Exosome_AI-removebg-preview.png

Introducing AI precision into every step of the development process

Picture1.png

 Discovering the hidden molecular mechanisms of stem cells and their secreted EVs

Picture2.png

 Identifying EV subpopulations with selective tropism and therapeutic effects using human tumor models and humanized animal models

Picture3.png

Precise scale-up production of EVs via real-time monitoring and AI analysis

Picture4.png

  Translating animal model results to humans – increasing prediction validity and applicability for clinical trials

Our Team

Eric_edited.png

Eric J. Messika

Ph.D. MBA, CEO

Brings over 25 years of experience as an entrepreneur, angel investor, senior executive, and director in numerous early-stage biotech companies.

He has a Ph.D. in immunology from the Hebrew University and was an HHMI research associate at Stanford University.

image.png

Aharon Brodie

Ph.D. CTO

PhD in bioinformatics. Data science experience in the fields of Bioinformatics and Computer

Science. Data analysis in cancer therapeutics, anti-aging, and

degenerative diseases. Patents and publications related to big data and disease analysis.

Chaya.jpg

Chaya Brodie

Ph.D. Consultant

Professor in the Faculty of Life Sciences and the Nanotechnology Center, Bar-Ilan University. Extensive research experience in cell and molecular biology  and the areas of cancer, stem cells, and extracellular vesicles

Want to know more?

bottom of page